topotecan
Showing 26 - 50 of 163
Retinoblastoma Trial in Memphis (drug, other, procedure, radiation)
Recruiting
- Retinoblastoma
- vincristine
- +11 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Aug 25, 2022
Neuroblastoma, Medulloblastoma Trial in United States (Nifurtimox, Cyclophosphamide, Topotecan)
Completed
- Neuroblastoma
- Medulloblastoma
- Nifurtimox
- +2 more
-
San Diego, California
- +14 more
Dec 28, 2022
Eye Cancer, Retinoblastoma Trial in Lausanne (Topotecan, Melphalan)
Recruiting
- Eye Cancer, Retinoblastoma
- Topotecan
- Melphalan
-
Lausanne, SwitzerlandCHUV Lausanne University Hospital
Nov 18, 2021
Small-cell Lung Cancer Trial in Worldwide (Berzosertib, Topotecan)
Active, not recruiting
- Small-cell Lung Cancer
- Berzosertib
- Topotecan
-
Santa Rosa, California
- +47 more
Jun 24, 2022
Ewing Sarcoma, Myxoid Liposarcoma, Sarcoma,Soft Tissue Trial in United States (Seclidemstat, Cyclophosphamide, Topotecan)
Recruiting
- Ewing Sarcoma
- +10 more
- Seclidemstat
- +2 more
-
Los Angeles, California
- +16 more
Jan 18, 2022
Ovarian Cancer Trial in Beijing (BD0801, Paclitaxel, Placebo)
Recruiting
- Ovarian Cancer
- BD0801
- +4 more
-
Beijing, Beijing, ChinaCancer Hospital Chinese Academy of Medical Sciences
Nov 24, 2021
Small Cell Lung Cancer Trial in Worldwide (Trilaciclib, Placebo, Topotecan)
Glioblastoma, Glioblastoma Multiforme, Gliosarcoma Trial run by the NCI (topotecan, pazopanib)
Completed
- Glioblastoma
- +4 more
- topotecan
- pazopanib
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 3, 2020
Solid Tumor, Colorectal Cancer, Cholangiocarcinoma Trial in France, United States (TRK-950, Irinotecan, Leucovorin)
Recruiting
- Solid Tumor
- +11 more
- TRK-950
- +14 more
-
Scottsdale, Arizona
- +13 more
Oct 2, 2022
Ganglioneuroblastoma, High Risk Neuroblastoma Trial in Australia, New Zealand, United States (procedure, drug, biological,
Active, not recruiting
- Ganglioneuroblastoma
- High Risk Neuroblastoma
- Autologous Hematopoietic Stem Cell Transplantation
- +14 more
-
Los Angeles, California
- +9 more
Sep 1, 2022
Platinum-resistant Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Canada, United States (Nemvaleukin
Recruiting
- Platinum-resistant Ovarian Cancer
- +2 more
- Nemvaleukin and Pembrolizumab Combination
- +6 more
-
Ventura, California
- +7 more
Aug 5, 2022
Very High Risk Neuroblastoma Trial in Villejuif, Utrecht (radiation, drug, procedure)
Recruiting
- Very High Risk Neuroblastoma
- 131I-mIBG
- +3 more
-
Villejuif, Val De Marne, France
- +1 more
May 31, 2021
Relapsed Small Cell Lung Cancer Trial in Worldwide (Irinotecan, Lurbinectedin, Topotecan)
Recruiting
- Relapsed Small Cell Lung Cancer
- Irinotecan
- +2 more
-
Joliet, Illinois
- +94 more
Aug 12, 2022
Malignant Rhabdoid Tumor, Atypical Teratoid Rhabdoid Tumor Trial in United States (drug, procedure, radiation)
Recruiting
- Malignant Rhabdoid Tumor
- Atypical Teratoid Rhabdoid Tumor
- alisertib
- +9 more
-
Los Angeles, California
- +10 more
Aug 1, 2022
Small Cell Lung Cancer Trial in Worldwide (Irinotecan liposome injection, Topotecan)
Active, not recruiting
- Small Cell Lung Cancer
- Irinotecan liposome injection
- Topotecan
-
Denver, Colorado
- +117 more
Nov 22, 2022
Advanced Malignant Solid Tumor, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8
Recruiting
- Advanced Malignant Solid Neoplasm
- +28 more
- Capecitabine
- +16 more
-
Conroe, Texas
- +4 more
Dec 5, 2022
Neuroblastoma Trial in Worldwide (LY3295668 Erbumine, Topotecan, Cyclophosphamide)
Active, not recruiting
- Neuroblastoma
- LY3295668 Erbumine
- +2 more
-
San Francisco, California
- +21 more
Aug 17, 2022
Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Neuroblastoma Trial in Worldwide (Idasanutlin, Venetoclax,
Recruiting
- Acute Myeloid Leukemia (AML)
- +3 more
- Idasanutlin
- +6 more
-
Phoenix, Arizona
- +19 more
Jan 18, 2023
Children, Adolescents and Young Adults With Refractory or Recurrent Malignancies Trial in Worldwide (Ribociclib, Topotecan,
Unknown status
- Children, Adolescents and Young Adults With Refractory or Recurrent Malignancies
- Ribociclib
- +9 more
-
Copenhagen, Denmark
- +6 more
Feb 23, 2021
Extensive Stage Small Cell Lung Cancer Trial in Beijing (nab-paclitaxel, Topotecan)
Unknown status
- Extensive Stage Small Cell Lung Cancer
- nab-paclitaxel
- Topotecan
-
Beijing, Beijing, ChinaCancer Hospital Chinese Academy of Medical Sciences
Dec 27, 2019